Access cutting-edge acute kidney injury treatment through this clinical trial at a research site in Ocala. Study-provided care at no cost to qualified participants.
Access acute kidney injury specialists in Ocala at no cost
This study follows strict safety protocols and ethical guidelines
All study-related acute kidney injury treatment provided free
This phase 2 study is to assess the safety and efficacy of APX-115 active doses in Contrast Induced Acute Kidney Disease compared to placebo following multiple oral dosing in patients with undergoing percutaneous coronary intervention. It is anticipated that approximately 280 patients will be randomized into the study in a 1:1 ratio to 400 mg APX-115 (Isuzinaxib hydrochloride) or placebo arm.
Sponsor: Aptabio Therapeutics, Inc.
Check if you qualify for this acute kidney injury clinical trial in Ocala, FL
If you're searching for acute kidney injury treatment options in Ocala, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Ocala research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute kidney injury specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.